This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Eli Lilly & Company
Drug Names(s): LY3023703
Description: LY30223703 is designed to inhibit the microsomal prostaglandin E synthase-1 enzyme (mPGES-1) thus affecting the metabolism of eicosanoids and glutathiones.
Additional information available to subscribers only: